1
This presentation includes forward-looking statements. Including statements regarding the timing and outcome of product development, potential regulatory approvals, future demand for and sales of our products and future development of new products. These statements are not guarantees of future performance and actual results could differ materially and adversely from those expressed in any forward looking statements. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. The Company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
Pioneered Pharmaceuticals trading platform S2P ( supplier to Pharmacy ). Over 8,700 Pharmacies already on the Company ’ s network . The Company ’ s centralized, efficient Platform helps ( avoid the negative reimbursement costs ) and identify the best available price for prescription drugs . Adding 100 + new pharmacies per month . Targeting to reach most, if not all, of the 24,000 independent pharmacies, with combines annual purchasing power of over $ 92 billion . Pharmacies on the Platform have no contract or fee obligations -- similar to eBay & Amazon . Trxade earns a transaction fee from sellers on the platform .
The U.S. pharmaceutical is a $330 billion per year industry, with over 65,000 pharmacy facilities and 1,500 State-licensed suppliers. Besides several large national chains, there are 24,000 independent pharmacies in US. Typical independent pharmacy is owned by 60 + year old individual. Average annual sales per pharmacy are approximately $ 3.5million Trxade Platform allows the independents to keep up with up- to- the- minute pricing on a cost effective basis. Most independents are understaffed and mindful of the bottom line. Suppliers are known to reprice inventory on a daily basis. 4
Pharmacies compare and purchase drugs on platform and save money 1. Negative Reimbursement savings 2. Advantages in purchase price. Utilizes proprietary database and algorithms to identify pharmaceutical products that are likely to be in short supply and bring them on Pharmacies. 5 TRxADE IS THE LARGEST ONLINE PHARMACEUTICAL MARKETPLACE PLATFORM IN THE US
Safe, Secure easy to use Web-Based Platform. The Platform allows pharmacies to compare the drugs offered by various suppliers and select the most favorable deals. Access to Multiple Supplier Sources. Easy layout for Price Comparison & for Purchasing. Price Transparency Supplier Competition – Lowest Prices There are no membership or transaction fees for pharmacies. Lowers the pharmacy’s total annual purchase costs by 7 - 10%. Saves money, time and adds up to10% to their bottom line profits.
ORGANIC GROWTH Currently adding 100+ Pharmacies per month to the Platform Expansion achieved thru Direct Marketing, email Marketing, trade conferences. TrXade Account team hand holds for 5 purchases. TrXade charge 5% on each transaction value for generic drugs and 0.25% for Branded drugs. The existing 8,300 Pharmacies on TrXade’s Platform are spread in over 50 states of USA. INORGANIC GROWTH Increase percentage purchase per month per pharmacy. Adding Payment gateway Adding multiple sales channels, such as goods other than Drugs. Putting Telemedicine's counters at Independent pharmacies 7
TRXADE currently has approximately 8,700 pharmacies registered as users of the platform Our revenue growth on this platform will come from two primary sources: 1. Increases in the number of registered users 2. Increases in the utilization rate of the trading platform among registered users The table below shows the revenue growth opportunity by varying numbers of registered users and utilization rates ANNUALIZED REVENUE POTENTIAL FROM S2P PLATFORM NUMBER OF PHARMACIES UTILIZING THE TRXADE PLATFORM 1,000 1,200 1,400 1,600 1,800 2,000 2,200 2,400 2,600 2,800 10% $ 18,000,000 $ 21,600,000 $ 25,200,000 $ 28,800,000 $ 32,400,000 $ 36,000,000 $ 39,600,000 $ 43,200,000 $ 46,800,000 $ 50,400,000 % OF PRODUCT PURCHASED 20% $ 36,000,000 $ 43,200,000 $ 50,400,000 $ 57,600,000 $ 64,800,000 $ 72,000,000 $ 79,200,000 $ 86,400,000 $ 93,600,000 $ 100,800,000 THROUGH TRXADE 30% $ 54,000,000 $ 64,800,000 $ 75,600,000 $ 86,400,000 $ 97,200,000 $ 108,000,000 $ 118,800,000 $ 129,600,000 $ 140,400,000 $ 151,200,000 40% $ 72,000,000 $ 86,400,000 $ 100,800,000 $ 115,200,000 $ 129,600,000 $ 144,000,000 $ 158,400,000 $ 172,800,000 $ 187,200,000 $ 201,600,000 50% $ 90,000,000 $ 108,000,000 $ 126,000,000 $ 144,000,000 $ 162,000,000 $ 180,000,000 $ 198,000,000 $ 216,000,000 $ 234,000,000 $ 252,000,000 60% $ 108,000,000 $ 129,600,000 $ 151,200,000 $ 172,800,000 $ 194,400,000 $ 216,000,000 $ 237,600,000 $ 259,200,000 $ 280,800,000 $ 302,400,000 70% $ 126,000,000 $ 151,200,000 $ 176,400,000 $ 201,600,000 $ 226,800,000 $ 252,000,000 $ 277,200,000 $ 302,400,000 $ 327,600,000 $ 352,800,000 80% $ 144,000,000 $ 172,800,000 $ 201,600,000 $ 230,400,000 $ 259,200,000 $ 288,000,000 $ 316,800,000 $ 345,600,000 $ 374,400,000 $ 403,200,000 90% $ 162,000,000 $ 194,400,000 $ 226,800,000 $ 259,200,000 $ 291,600,000 $ 324,000,000 $ 356,400,000 $ 388,800,000 $ 421,200,000 $ 453,600,000
Inventory RX provides U.S. licensed drug wholesalers and distributors with a convenient location to acquire prescription pharmaceuticals for resale Suppliers are able to list products for sale, purchase listed pharmaceuticals, as well as request pricing for needed product acquisitions. Quality pharmaceuticals at significant discounts Sales & purchasing opportunities for a large network of suppliers Price comparisons of multiple suppliers with ONE Search Simplified ordering to suppliers of choice Analytical and price comparison tools for suppliers to make educated buying and selling decisions.
COMPETITION www.Pharmsaver.com 750 pharmacies on their platform www.CherrypickRx.com 300 Pharmacies on their platform www.bidrx.com 1200 pharmacies on their platform TRXADE ADVANTAGES : Trxade.com has a significant first mover advantage over its competitors operating similar e-commerce platforms. Better Data Analytics Improved Pricing Analytics TrXade runs its own Algorithms 10
Trxade stays on the cutting edge of technology to ensure consistent growth and market share. This illustration represents the historical and projected growth of the platform: Phase 4 Inventory Rx – National Marketing Campaign / Contract Manufacturing Phase 2: RxGuru App - Improvements to Phase 5: Addition of Functionality and New Industry Sectors Design (Hospitals, Veterinary, Long-Term Care) Phase 3: Bulk Upload – Ability for Phase 1: Trxade Rx – Buyers to Compare & Purchase National launch & against their Primary Supplier. marketing campaign 11
Board of Directors Michael Peterson- President and CEO of Pedevco Corp (NYSE: PED) Donald Fell- Director/Professor Foundation for Teaching Economics Suren Ajjarapu– Chairman/CEO. Mr. Ajjarapu is a serial entrepreneur. He was the Founder & CEO of Trxade Group ( OTCQB: TRXD), Sansur Renewable Energy, Aemetis, Inc. (NASDAQ: AMTX), and Global Information Technology, Inc. Mr. Ajjarapu arranged to list these companies on NASDAQ and raised $ 135 million aggregate financings for these companies. He holds a Masters Degree in Environmental Engineering, A MBA in International Finance and Management. Mr. Ajjarapu is also a graduate of the Venture Capital & Private Equity Program from Harvard University. Prashant Patel – President & COO. Mr. Patel is a Registered Pharmacist and pharmaceutical consultant with over 10 years experience in Pharmacy operations and logistics. Mr. Patel has also been the Founder and Operator of several independent pharmacies. He is a graduate of Nottingham University School of Pharmacy and has a Masters Degree in Finance from the Cass Business School, UK. Jariel Morales– EVP of. He has over 20yrs of experience in Marketing , leads the marketing and product launch team through a data-driven methodology driving overall marketing operations, developing business segments, and expanding the reach of TRxADE, Group Inc.’s brand strategy, product marketing, and global awareness Jeff Davis – IT Head. He has over 20yrs of Experience in information Technology and leads the technology efforts of TRxADE Groups and platform tools of the company. He is Expert in automating business processes, developing research databases and customizing e-commerce platforms. Carol Lucas – VP of Operation. She has more than 15 years of experience in administration and Management. She manages a full range of Trxade operational duties. Responsibilities ranging from customer service to information technology. 12
Symbol TRXD:OTCQB* Fiscal Year End December 31 State of Incorporation Delaware Shares Outstanding ~31.95 million Management / Affiliate Ownership 26.44 million (81.3%)
Recommend
More recommend
